Gordon Naylor has applied the principles of engineering and science to his sterling international business career. As part of a small initial group which took CSL global, he brought world-class operational innovations which continue to underpin the success of the company. More recently he led the successful turnaround of the biotech vaccine company Seqiris. Gordon is passionate about restoring Australia's manufacturing competitiveness through enlightened public policies and innovation. He is now an angel investor in many Australian tech start-ups and through his family charity supports innovative solutions to Australian community problems.